La investigación médica española desembarca en Estados Unidos con Laminar Pharma
On January 2021, the researchers whose projects have received funding from the CAIB 2020 call of the...
19 February, 2021-
Next generation medicinesLearn moreWe design and develop drugs based on a novel therapeutic approach called melitherapy. -
A new pharmaceutical perspectiveLearn moreOur drugs are first-in-class molecules which target membrane lipids, instead of acting directly on proteins or DNA like other medicines.
-
Committed
to peopleLearn moreOur goal is to deliver reference treatments for illnesses with unmet medical needs, such as cancer and Alzheimer’s disease.
